The AMP 2017 Global Congress (April 3-5, 2017 in Berlin, Germany) highlighted a multi-disciplinary scientific program showcasing molecular technology with clinical applications in oncology, genetics, and infectious diseases. The emphasis was on modern, user-friendly laboratory analytics supported by informatics tools to facilitate interpretation of actionable genomic test results.

The purchase of this product provides you with downloadable PDF slides of many of the presentations given during the AMP 2017 Global Congress. See the "topics" tab for a list of all the presentations with slides available.


The digital files (PDFs) for the AMP Global Congress 2017 Meeting are available free to meeting registrants for a limited time (three months) after the conference.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical, except that AMP authorizes you to view, copy, download and print for your own purposes.



Course Information
Course Date:
April 03, 2017
Click on a topic name to see details and purchase options.
Monday April 3, 2017

Somatic Variant Interpretation and Reporting - The Informatics Underpinning in the Light of Recent AMP Guidelines  
Somak Roy, MD, Molecular and Genomic Pathology Laboratory UPMC, Pittsburgh, PA, USA


Complexities in the Analysis and Interpretation of NGS Data for Inherited Disorders
Avni B. Santani, PhD, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

Methods for Calling and Prioritzation of Somatic Variants from Panel, Exome and Genome Sequencing   
Dieter Beule, PhD, Berlin Institute of Health, Berlin, Germany


Validation of NGS Bioinformatics Pipelines: The AMP Working Group Guideline
Alexis B. Carter, MD, FCAP, FASCP, Children’s Healthcare of Atlanta, Atlanta, GA, USA

Linking Whole-Exome Cancer Sequencing Analysis with Therapeutics and Other Datasources
Aik Choon Tan, PhD, University of Colorado Anschutz Medical Campus, Aurora, CO, USA


What Have Public Databases Taught Us about Clinical Variant Classification
Stephen E. Lincoln, Invitae, San Francisco, CA, USA

Molecular Pathology Informatics - Infrastructures and Toolsets for Distributed and Scalable Cancer Genomics in Clinical Practice   
Mark J. Routbort, MD, PhD, MD Anderson Cancer Center, Houston, TX, USA


ClinGen Allele Registry, Pathogenicity Calculator, and the Emerging Computational Knowledge Resources for Clinical Genomics
Aleksandar Milosavljevic, PhD, Baylor College of Medicine, Houston, TX, USA

Tuesday April 4, 2017

Cancer Evolution as a Therapeutic Target
Mariangela Russo, PhD, University of Torino, Torino, Italy


Molecular Diagnostics in Myeloid Malignancies in the Era of NGS - Changing Paradigms
Christian Thiede, MD, University Hospital Carl Gustav Carus, Dresden, Germany

Circulating Tumor DNA in the Real World: Challenges and Opportunities    
Christina Lockwood, PhD, DABCC, DABMGG, University of Washington, Seattle, WA, USA


The Clinical Applications and Validation of Cell-free DNA-based Digital PCR Assays
Maria E. Arcila, MD, Memorial Sloan Kattering Cancer Center, New York, NY, USA

Next Generation Sequencing and Leukemia Diagnosis
Manja Meggendorfer, MD, MBA, MML Munich Leukemia Laboratory, Munich, Germany


Impact of NGS Data on Lymphoma Classification, Diagnosis and Treatment
Ioannis Anagnostopoulos, MD, PhD, Charité Universitätsmedizin Berlin, Germany

Choose Wisely: Comprehensive vs Targeted Genetic Tumor Profiling
Albrecht Stenzinger, MD, University Hospital Heidelberg, Heidelberg, Germany


Syndromic Infectious Disease Testing: Advantages, Challenges and Opportunities   
Melissa B. Miller, PhD, D(ABMM), UNC School of Medicine, Chapel Hill, NC, USA

Circulating Tumor Cells, Cell Free DNA, Liquid Biopsies    
Klaus Pantel, MD, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany


Targeted Sequencing in Small Tissue Biopsy Specimens
Mike Hubank, PhD, The Centre for Molecular Pathology, Royal Marsden Hospital, Surrey, United Kingdom

Molecular Prostate Cancer Heterogeneity
Peter J. Wild, MD, University Hospital Zurich, Zurich, Switzerland


Intratumoral Heterogeneity: Inferring How Human Tumors Grow
Darryl K. Shibata, MD, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA

Immunotherapy From the Pathologist's Perspective (PD-L1)   
Janis M. Taube, MD, MSc, Johns Hopkins University School of Medicine, Baltimore, MD, USA


Open Access PERSONAL Genomics and Epigenomics
Stephan Beck, PhD, FMedSci, University College London, London, United Kingdom

HPV-Induced Carcinogenesis and Viral Integration
Magnus von Knebel Doeberitz, MD, Heidelberg University Hospital, Heidelberg, Germany


Viral Carcinogenesis in Polyomavirus-Induced Carcinogenesis and Viral Integration
Axel zur Hausen, MD, PhD, Maastricht UMC+, Maastricht, Netherlands

Oral presentations of selected abstracts.


Infectious and Heritable Disease Presentations

New Syndrome: First Patient with Heterozygous Deleterious PIG-Q Mutations Causing a GPI-anchor Biosynthesis Deficiency
Lois J. Starr (Omaha, USA)


Simultaneous Detection and Typing of Alpha, Beta and Gamma HPV Using Target Enrichment and Whole Genome Sequencing
Tengguo Li (Atlanta, USA)


Rapid Detection and Identification of Uveitis Pathogens by Qualitative Multiplex Real Time PCR followed by High Resolution Melting
Paulo J. M. Bispo (Boston, USA)


Oncology and Drug Resistance Presentations

Clinical Evaluation of a Novel NGS-Based HIV-1 Drug Resistance Monitoring Test
Charlie Lee (Singapore, Singapore)


Targeted Bisulfite NGS of a DNA-methylation Multimarker Panel for Cancers of the Urinary Tract in Liquid Biopsies
Stefan Karst (Berlin, Germany)


Detect 0.1% Low Frequency Somatic Variants in Cell-free DNA Using Oncomine<sup>TM</sup> cfDNA Assays and Ion Torrent Sequencing
Jeff Schageman (Austin, USA)


Multi Institutional Evaluation of a High Sensitive NGS Assay for Liquid Biopsy Mutation Detection in Lung Cancer
Claudia Vollbrecht (Berlin, Germany)


Hematopathology Presentations

Small Customizable Next-Generation Sequencing Based Target Capture Panels in a Clinical Environment Can Detect Variant Mutations at Frequencies as Low as 0.5%
Lisa M. Chamberlain (San Diego, USA)


B- and T-Cell Immune Repertoire Characterization by Anchored Multiplex PCR and Next-Generation Sequencing
Jens Eberlein (Boulder, USA)

Wednesday April 5, 2017

The Triumph of MALDI-TOF Mass Spectrometry and New Developments in Tandem Mass Spectrometry for Clinical Microbiology   
Haroun N. Shah, PhD, Middlesex University, London, United Kingdom

Updates on the Guidelines for Lung Cancer Testing
Neal I. Lindeman, MD, Brigham & Women's Hospital, Boston, MA, USA


Classification of Brain Tumors by Methylation Analysis   
Andreas von Deimling, MD, University Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany


HER2 in Gastric Cancer    
Josef R&#252schoff, MD, Institute of Pathology Nordhessen, Targos Molecular Pathology GmbH, Kassel, Germany

The Human Gastrointestinal Microbiome and Advances in Metagenomic Medicine
James Versalovic, MD, PhD,  Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA


Update on the Use of Human Gene Expression for the Diagnosis of Infectious Diseases
Gregory A. Storch, MD, Washington University School of Medicine, St. Louis, MO, USA

NIPT Beyond Aneuploidy Screening
Rossa W.K. Chiu, MBBS, PhD, Chinese University of Hong Kong, Hong Kong


Molecular Testing of Urine for Detection of Cancer
Per Guldberg, PhD, Danish Cancer Society Research Center, Copenhagen, Denmark

Quality Assurance in Pathology: The QuiP Experience
Manfred Dietel, University Hospital Charité, Berlin, Germany

Good or Bad Sequencing Data?  Setting a Benchmark for the Quality of NGS in the Diagnostic Lab
Simon Patton, PhD, European Molecular Genetics Quality Network (EMQN), Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, United Kingdom

Individual topic purchase: Selected
AMP 2017 Global Congress Presentation PDFs
AMP Regular Member: $99.00
AMP Technologist Member: $99.00
AMP Associate Member: $99.00
Non-member Price: $599.00